Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17430761rdf:typepubmed:Citationlld:pubmed
pubmed-article:17430761lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:17430761lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:17430761lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:17430761lifeskim:mentionsumls-concept:C0041755lld:lifeskim
pubmed-article:17430761lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:17430761lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:17430761pubmed:issue2lld:pubmed
pubmed-article:17430761pubmed:dateCreated2007-4-13lld:pubmed
pubmed-article:17430761pubmed:abstractTextCutaneous drug reactions are among the most common types of adverse drug reactions. This article focuses on the recognition and management of severe cutaneous drug eruptions, including the drug-hypersensitivity syndrome, serum sickness-like reaction, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Cutaneous reactions are considered severe when they can result in serious skin damage or involve multiple organs. Some of these reactions can cause significant morbidity or death. Each may be confounded by diagnostic difficulties, confusion in ascertaining causality, and treatment challenges.lld:pubmed
pubmed-article:17430761pubmed:languageenglld:pubmed
pubmed-article:17430761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17430761pubmed:citationSubsetIMlld:pubmed
pubmed-article:17430761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17430761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17430761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17430761pubmed:statusMEDLINElld:pubmed
pubmed-article:17430761pubmed:monthAprlld:pubmed
pubmed-article:17430761pubmed:issn0733-8635lld:pubmed
pubmed-article:17430761pubmed:authorpubmed-author:ShearNeil HNHlld:pubmed
pubmed-article:17430761pubmed:authorpubmed-author:KnowlesSandra...lld:pubmed
pubmed-article:17430761pubmed:issnTypePrintlld:pubmed
pubmed-article:17430761pubmed:volume25lld:pubmed
pubmed-article:17430761pubmed:ownerNLMlld:pubmed
pubmed-article:17430761pubmed:authorsCompleteYlld:pubmed
pubmed-article:17430761pubmed:pagination245-53, viiilld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:meshHeadingpubmed-meshheading:17430761...lld:pubmed
pubmed-article:17430761pubmed:year2007lld:pubmed
pubmed-article:17430761pubmed:articleTitleRecognition and management of severe cutaneous drug reactions.lld:pubmed
pubmed-article:17430761pubmed:affiliationFaculty of Pharmacy, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada.lld:pubmed
pubmed-article:17430761pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17430761pubmed:publicationTypeReviewlld:pubmed